Please assess the completion status of the following clinical trial:

Trial Title: Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject must be given free and informed consent and signed the consent~* Subject must be affiliated or beneficiary in a health insurance plan~* Subject included in our previous study (RBC No: 2011-A00646-35; NCT03098784)~Exclusion Criteria:~- Subject has a cons-indication (or an incompatible combination therapy) for the realization of the EFR.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Air France Company's Employees Working (Type: None): Observational cohort : Air France Company's Employees Working in the Marseilles and Paris Airports having Respiratoy health, biological investigations

Based on this trial design, predict the completion outcome and termination type (if applicable).